Dong-A’s Nenoma sales picking up the pace

Published: 2013-10-22 06:57:00

Updated: 2013-10-22 06:57:00

Dong-A ST’s Nenoma (clomipramine) is enjoying robust sales in the domestic premature ejaculation (PE) predominated by Menarini’s Priligy (dapoxetine) since its release two months ago.

The company saw the number of prescription increase by 30.6 percent in September, challenging Priligy (33 perc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK